Want to join the conversation?
$NKTR said it published pre-clinical results for NKTR-214, an investigational CD122-biased immune-stimulatory cytokine for the treatment of cancer in Clinical Cancer Research. The new paper documents durable anti-tumor efficacy, safety and immune mechanism of action of NKTR-214 in multiple tumor models.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.